CNSP
Price
$0.88
Change
+$0.04 (+4.76%)
Updated
Jun 27 closing price
Capitalization
4.8M
VIGL
Price
$7.95
Change
-$0.00 (-0.00%)
Updated
Jun 27 closing price
Capitalization
370.81M
44 days until earnings call
Interact to see
Advertisement

CNSP vs VIGL

Header iconCNSP vs VIGL Comparison
Open Charts CNSP vs VIGLBanner chart's image
CNS Pharmaceuticals
Price$0.88
Change+$0.04 (+4.76%)
Volume$240.31K
Capitalization4.8M
Vigil Neuroscience
Price$7.95
Change-$0.00 (-0.00%)
Volume$303.98K
Capitalization370.81M
CNSP vs VIGL Comparison Chart in %
Loading...
CNSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VIGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CNSP vs. VIGL commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNSP is a Buy and VIGL is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (CNSP: $0.88 vs. VIGL: $7.95)
Brand notoriety: CNSP and VIGL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CNSP: 11% vs. VIGL: 22%
Market capitalization -- CNSP: $4.8M vs. VIGL: $371.04M
CNSP [@Biotechnology] is valued at $4.8M. VIGL’s [@Biotechnology] market capitalization is $371.04M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CNSP’s FA Score shows that 1 FA rating(s) are green whileVIGL’s FA Score has 0 green FA rating(s).

  • CNSP’s FA Score: 1 green, 4 red.
  • VIGL’s FA Score: 0 green, 5 red.
According to our system of comparison, both CNSP and VIGL are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CNSP’s TA Score shows that 5 TA indicator(s) are bullish while VIGL’s TA Score has 3 bullish TA indicator(s).

  • CNSP’s TA Score: 5 bullish, 3 bearish.
  • VIGL’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, CNSP is a better buy in the short-term than VIGL.

Price Growth

CNSP (@Biotechnology) experienced а +14.01% price change this week, while VIGL (@Biotechnology) price change was +0.38% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

VIGL is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VIGL($371M) has a higher market cap than CNSP($4.8M). VIGL YTD gains are higher at: 367.647 vs. CNSP (-85.399). CNSP has higher annual earnings (EBITDA): -15.6M vs. VIGL (-91.27M). VIGL has more cash in the bank: 87.1M vs. CNSP (13M). CNSP has less debt than VIGL: CNSP (211K) vs VIGL (12.7M). CNSP (0) and VIGL (0) have equivalent revenues.
CNSPVIGLCNSP / VIGL
Capitalization4.8M371M1%
EBITDA-15.6M-91.27M17%
Gain YTD-85.399367.647-23%
P/E Ratio0.00N/A-
Revenue00-
Total Cash13M87.1M15%
Total Debt211K12.7M2%
TECHNICAL ANALYSIS
Technical Analysis
CNSPVIGL
RSI
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 4 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 3 days ago
88%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 3 days ago
90%
MACD
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 3 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
88%
Advances
ODDS (%)
Bullish Trend 3 days ago
85%
N/A
Declines
ODDS (%)
Bearish Trend 17 days ago
90%
N/A
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 3 days ago
86%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
CNSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VIGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
POSAF0.05N/A
+0.57%
Posabit Systems Corporation
FPAFF0.75N/A
N/A
First Pacific Company Ltd.
SHMUY43.65N/A
N/A
Shimizu Corp.
TAGP0.05N/A
N/A
Tristar Acquisition Group
STOHF24.89-0.67
-2.63%
Equinor ASA

CNSP and

Correlation & Price change

A.I.dvisor indicates that over the last year, CNSP has been loosely correlated with BRCTF. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if CNSP jumps, then BRCTF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNSP
1D Price
Change %
CNSP100%
+5.02%
BRCTF - CNSP
37%
Loosely correlated
N/A
PTGX - CNSP
27%
Poorly correlated
+0.86%
NRIX - CNSP
26%
Poorly correlated
+0.17%
MGNX - CNSP
26%
Poorly correlated
-6.30%
VIGL - CNSP
25%
Poorly correlated
N/A
More

VIGL and

Correlation & Price change

A.I.dvisor indicates that over the last year, VIGL has been loosely correlated with MRUS. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if VIGL jumps, then MRUS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VIGL
1D Price
Change %
VIGL100%
N/A
MRUS - VIGL
49%
Loosely correlated
-0.47%
IMNN - VIGL
46%
Loosely correlated
-7.34%
ELVN - VIGL
35%
Loosely correlated
-3.95%
VYGR - VIGL
32%
Poorly correlated
-0.34%
VTGN - VIGL
31%
Poorly correlated
-3.90%
More